Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

PetVivo Holdings, Inc. (PETV)

2.97   0.03 (1.02%) 03-24 16:00
Open: 2.967 Pre. Close: 2.94
High: 2.9973 Low: 2.87
Volume: 20,444 Market Cap: 32(M)

Technical analysis

as of: 2023-03-24 4:28:45 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 3.82     One year: 4.2
Support: Support1: 2.74    Support2: 2.27
Resistance: Resistance1: 3.27    Resistance2: 3.59
Pivot: 3.1
Moving Average: MA(5): 2.98     MA(20): 3.08
MA(100): 2.55     MA(250): 2.27
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 24.8     %D(3): 28.3
RSI: RSI(14): 49.5
52-week: High: 3.59  Low: 1.23
Average Vol(K): 3-Month: 35 (K)  10-Days: 46 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ PETV ] has closed above bottom band by 32.1%. Bollinger Bands are 24.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3 - 3.01 3.01 - 3.03
Low: 2.84 - 2.85 2.85 - 2.87
Close: 2.95 - 2.97 2.97 - 2.99

Company Description

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

Headline News

Fri, 17 Mar 2023
Clinical Study Results Involving Spryng, a PetVivo Holdings, Inc ... - GlobeNewswire

Fri, 10 Mar 2023
PetVivo Holdings, Inc. to Exhibit and Dr. Erik Kleeman of Ethos ... - GlobeNewswire

Mon, 13 Feb 2023
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE WESTERN ... - GlobeNewswire

Mon, 13 Feb 2023
PetVivo Holdings, Inc. (NASDAQ:PETV) Q3 2023 Earnings Call Transcript - Yahoo Finance

Thu, 26 Jan 2023
PETVIVO HOLDINGS, INC. TO PARTICIPATE IN THE LYTHAM - GlobeNewswire

Mon, 23 Jan 2023
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE 44TH LAKE TAHOE - GlobeNewswire

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. -4 (M)
Shares Float 0 (M)
% Held by Insiders 1.073e+007 (%)
% Held by Institutions 6.44e+006 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -85570
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.63
Profit Margin (%) 0
Operating Margin (%) -1
Return on Assets (ttm) 938.6
Return on Equity (ttm) -67.4
Qtrly Rev. Growth 387920
Gross Profit (p.s.) -0.01
Sales Per Share 0.07
EBITDA (p.s.) -0.75
Qtrly Earnings Growth -7.42e+006
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value -4.75
Price to Sales 37.97
Price to Cash Flow 0

Stock Dividends

Dividend 143070
Forward Dividend 158380
Dividend Yield 4817170%
Dividend Pay Date 2020-12-29
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.